Survey of Intravitreal Injection Preferences for the Treatment of Age-Related Macular Degeneration and Macular Edema Among Members of the Turkish Ophthalmological Association

KARABAŞ, VEYSEL; Tokuc, ECEM; ŞERMET, FİGEN

doi:10.4274/tjo.galenos.2021.37075

Survey of Intravitreal Injection Preferences for the Treatment of Age-Related Macular Degeneration and Macular Edema Among Members of the Turkish Ophthalmological Association

Copy For Citation

KARABAŞ V. L., Tokuc E., ŞERMET F.

TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY, vol.52, no.3, pp.179-185, 2022 (ESCI)

Publication Type: Article / Article
Volume: 52 Issue: 3
Publication Date: 2022
Doi Number: 10.4274/tjo.galenos.2021.37075
Journal Name: TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY
Journal Indexes: Emerging Sources Citation Index (ESCI), Directory of Open Access Journals
Page Numbers: pp.179-185
Keywords: Anti-VEGF, bevacizumab, aflibercept, ranibizumab, off-label, diabetic macular edema, age-related macular degeneration, retinal vein occlusion, BEVACIZUMAB, RANIBIZUMAB, AFLIBERCEPT, STERILITY, SAFETY
Kocaeli University Affiliated: Yes

Abstract

Objectives: To analyze the current preferences of ophthalmologists for the treatment of macular edema and age-related macular degeneration (AMD) and to evaluate off-label use of bevacizumab in Turkey.